Bayesian leveraging of historical control data for a clinical trial with time-to-event endpoint
From MaRDI portal
(Redirected from Publication:6627508)
Cites work
- Bayesian statistics and the efficiency and ethics of clinical trials
- Determining the Effective Sample Size of a Parametric Prior
- Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials
- scientific article; zbMATH DE number 3844820 (Why is no real title available?)
- scientific article; zbMATH DE number 4102269 (Why is no real title available?)
- Robust meta‐analytic‐predictive priors in clinical trials with historical control information
- Semiparametric Bayesian commensurate survival model for post-market medical device surveillance with non-exchangeable historical data
- Statistical Analysis of Financial Data in S-Plus
Cited in
(8)- BEAST: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpoints
- On efficient posterior inference in normalized power prior Bayesian analysis
- A Bayesian adaptive design for dual-agent phase I-II oncology trials integrating efficacy data across stages
- Dual-criterion approach incorporating historical information to seek accelerated approval with application in time-to-event group sequential trials
- A novel Phase II single-arm hybrid design to minimize trial duration and enhance subsequent Phase III trial success rate
- Bayesian borrowing with multiple heterogeneous historical studies using order restricted normalized power prior
- The scale transformed power prior for time-to-event data
- On the interplay between prior weight and variance of the robustification component in robust mixture prior Bayesian dynamic borrowing approach
This page was built for publication: Bayesian leveraging of historical control data for a clinical trial with time-to-event endpoint
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6627508)
